Endothelial dysfunction in tristetraprolin-deficient mice is not caused by enhanced tumor necrosis factor-α expression

Journal of Biological Chemistry

Volumn 289, Issue 22, 2014, Pages 15653-15665

  Bollmann, Franziska ^a   Wu, Zhixiong ^a   Oelze, Matthias ^a   Siuda, Daniel ^a   Xia, Ning ^a   Henke, Jenny ^a   Daiber, Andreas ^a   Li, Huige ^a   Stumpo, Deborah J ^b   Blackshear, Perry J ^b   Kleinert, Hartmut ^a   Pautz, Andrea ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALS;

ATHEROGENESIS; CARDIOVASCULAR EVENT; CHRONIC INFLAMMATION; ENDOTHELIAL DYSFUNCTION; INFLAMMATORY DISEASE; REACTIVE OXYGEN SPECIES; TRISTETRAPROLIN; TUMOR NECROSIS FACTORS;

PATHOLOGY;

CALGRANULIN A; CATHEPSIN S; COLLAGEN TYPE 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; OSTEOPONTIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; ENDOTHELIAL DYSFUNCTION; GENE; GENE EXPRESSION; GENE INACTIVATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA STABILITY; TNF ALPHA GENE; VASODILATATION;

ATHEROSCLEROSIS; ENDOTHELIAL DYSFUNCTION; NADPH OXIDASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES (ROS); TUMOR NECROSIS FACTOR (TNF);

ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; CHRONIC DISEASE; ENDOTHELIAL CELLS; FEMALE; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; NADPH OXIDASE; ORGAN CULTURE TECHNIQUES; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RNA STABILITY; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 84901705314     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.566984     Document Type: Article

References (70)

1. Hansson, G. K., Robertson, A. K., and Söderberg-Nauclér, C. (2006) Inflammation and atherosclerosis. Annu. Rev. Pathol. 1, 297-329
2. Dai, X. Y., Cai, Y., Sun, W., Ding, Y., Wang, W., Kong, W., Tang, C., Zhu, Y., Xu, M. J., and Wang, X. (2014) Intermedin inhibits macrophage foamcell formation via tristetraprolin-mediated decay of CD36 mRNA. Cardiovasc. Res. 101, 297-305
3. Jamal Uddin, M., Joe, Y., Zheng, M., Blackshear, P. J., Ryter, S. W., Park, J. W., and Chung, H. T. (2013) A functional link between heme oxygenase- 1 and tristetraprolin in the anti-inflammatory effects of nicotine. Free Radic. Biol. Med. 65, 1331-1339
4. Cao, H., Cao, F., Roussel, A. M., and Anderson, R. A. (2013) Quantitative PCR for glucose transporter and tristetraprolin family gene expression in cultured mouse adipocytes and macrophages. In Vitro Cell. Dev. Biol. Anim. 49, 759-770
5. Galkina, E., and Ley, K. (2009) Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol. 27, 165-197
6. Aviña-Zubieta, J. A., Choi, H. K., Sadatsafavi, M., Etminan, M., Esdaile, J. M., and Lacaille, D. (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Rheum. 59, 1690-1697
7. Roman, M. J., Moeller, E., Davis, A., Paget, S. A., Crow, M. K., Lockshin, M. D., Sammaritano, L., Devereux, R. B., Schwartz, J. E., Levine, D. M., and Salmon, J. E. (2006) Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann. Intern. Med. 144, 249-256
8. Maradit-Kremers, H., Nicola, P. J., Crowson, C. S., Ballman, K. V., and Gabriel, S. E. (2005) Cardiovascular death in rheumatoid arthritis: A population- based study. Arthritis Rheum. 52, 722-732
9. del Rincón, I. D., Williams, K., Stern, M. P., Freeman, G. L., and Escalante, A. (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 44, 2737-2745
10. Gabriel, S. E. (2008) Cardiovascular morbidity and mortality in rheumatoid arthritis. Am. J. Med. 121, S9-14
11. Iademarco, M. F., Barks, J. L., and Dean, D. C. (1995) Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J. Clin. Invest. 95, 264-271
12. Jayakody, L., Kappagoda, T., Senaratne, M. P., and Thomson, A. B. (1988) Impairment of endothelium-dependent relaxation: An early marker for atherosclerosis in the rabbit. Br. J. Pharmacol. 94, 335-346
13. Griendling, K. K., and FitzGerald, G. A. (2003) Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108, 2034-2040
14. Münzel, T., Daiber, A., Ullrich, V., and Mülsch, A. (2005) Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler. Thromb. Vasc. Biol. 25, 1551-1557
15. Förstermann, U., and Münzel, T. (2006) Endothelial nitric-oxide synthase in vascular disease: from marvel to menace. Circulation 113, 1708-1714
16. Bosello, S., Santoliquido, A., Zoli, A., Di Campli, C., Flore, R., Tondi, P., and Ferraccioli, G. (2008) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. Clin. Rheumatol. 27, 833-839
17. Chen, C. Y., and Shyu, A. B. (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20, 465-470
18. Brooks, S. A., and Blackshear, P. J. (2013) Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action. Biochim. Biophys. Acta 1829, 666-679
19. Carballo, E., Lai, W. S., and Blackshear, P. J. (1998) Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281, 1001-1005
20. Kang, J. G., Amar, M. J., Remaley, A. T., Kwon, J., Blackshear, P. J., Wang, P. Y., and Hwang, P. M. (2011) Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation. J. Immunol. 187, 2696-2701
21. Blackshear, P. J. (2002) Tristetraprolin and other CCCH tandem zincfinger proteins in the regulation of mRNA turnover. Biochem. Soc. Trans. 30, 945-952
22. Ghosh, S., Hoenerhoff, M. J., Clayton, N., Myers, P., Stumpo, D. J., Maronpot, R. R., and Blackshear, P. J. (2010) Left-sided cardiac valvulitis in tristetraprolin- deficient mice: The role of tumor necrosis factor α. Am. J. Pathol. 176, 1484-1493
23. Taylor, G. A., Carballo, E., Lee, D. M., Lai, W. S., Thompson, M. J., Patel, D. D., Schenkman, D. I., Gilkeson, G. S., Broxmeyer, H. E., Haynes, B. F., and Blackshear, P. J. (1996)Apathogenetic role for TNFα in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4, 445-454
24. Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., and Braunwald, E. (2000) Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 101, 2149-2153
25. Mori, L., Loetscher, H., Kakimoto, K., Bluethmann, H., and Steinmetz, M. (1992) Expression of a transgenic T cell receptor β chain enhances collagen- induced arthritis. J. Exp. Med. 176, 381-388
26. Schmidt, N., Art, J., Forsch, I., Werner, A., Erkel, G., Jung, M., Horke, S., Kleinert, H., and Pautz, A. (2012) The anti-inflammatory fungal compound (S)-curvularin reduces proinflammatory gene expression in an in vivo model of rheumatoid arthritis. J. Pharmacol. Exp. Ther. 343, 106-114
27. Ray, A., and Dittel, B. N. (2010) Isolation of mouse peritoneal cavity cells. J. Vis. Exp. 35, e1488
28. Li, H., Hergert, S. M., Schäfer, S. C., Brausch, I., Yao, Y., Huang, Q., Mang, C., Lehr, H. A., and Förstermann, U. (2005) Midostaurin up-regulates eNOS gene expression and preserves eNOS function in the microcirculation of the mouse. Nitric Oxide 12, 231-236
29. Friedewald, W. T., Levy, R. I., and Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, with- out use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502
30. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159
31. Schmidt, N., Pautz, A., Art, J., Rauschkolb, P., Jung, M., Erkel, G., Goldring, M. B., and Kleinert, H. (2010) Transcriptional and post-transcriptional regulation of iNOS expression in human chondrocytes. Biochem. Pharmacol. 79, 722-732
32. Siuda, D., Zechner, U., El Hajj, N., Prawitt, D., Langer, D., Xia, N., Horke, S., Pautz, A., Kleinert, H., Förstermann, U., and Li, H. (2012) Transcriptional regulation of Nox4 by histone deacetylases in human endothelial cells. Basic Res. Cardiol. 107, 283
33. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-[/Delta][/Delta] C(T)) method. Methods 25, 402-408
34. Daiber, A., August, M., Baldus, S., Wendt, M., Oelze, M., Sydow, K., Kleschyov, A. L., and Munzel, T. (2004) Measurement of NAD(P)H oxidasederived superoxide with the luminol analogue L-012. Free Radic. Biol. Med. 36, 101-111
35. Oelze, M., Daiber, A., Brandes, R. P., Hortmann, M., Wenzel, P., Hink, U., Schulz, E., Mollnau, H., von Sandersleben, A., Kleschyov, A. L., Mülsch, A., Li, H., Förstermann, U., and Münzel, T. (2006) Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 48, 677-684
36. Schuhmacher, S., Wenzel, P., Schulz, E., Oelze, M., Mang, C., Kamuf, J., Gori, T., Jansen, T., Knorr, M., Karbach, S., Hortmann, M., Mäthner, F., Bhatnagar, A., Förstermann, U., Li, H., Münzel, T., and Daiber, A. (2010) Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1. Hypertension 55, 897-904
37. Knorr, M., Hausding, M., Kröller-Schuhmacher, S., Steven, S., Oelze, M., Heeren, T., Scholz, A., Gori, T., Wenzel, P., Schulz, E., Daiber, A., and Münzel, T. (2011) Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan. Arterioscler. Thromb. Vasc. Biol. 31, 2223-2231
38. Sukhova, G. K., Zhang, Y., Pan, J. H., Wada, Y., Yamamoto, T., Naito, M., Kodama, T., Tsimikas, S., Witztum, J. L., Lu, M. L., Sakara, Y., Chin, M. T., Libby, P., and Shi, G. P. (2003) Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 111, 897-906
39. Scatena, M., Liaw, L., and Giachelli, C. M. (2007) Osteopontin: A multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 27, 2302-2309
40. Bobryshev, Y. V., and Lord, R. S. (2002) Expression of heat shock protein- 70 by dendritic cells in the arterial intima and its potential significance in atherogenesis. J. Vasc. Surg. 35, 368-375
41. Pendyala, S., Gorshkova, I. A., Usatyuk, P. V., He, D., Pennathur, A., Lambeth, J. D., Thannickal, V. J., and Natarajan, V. (2009) Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells. Antioxid. Redox Signal. 11, 747-764
42. Branén, L., Hovgaard, L., Nitulescu, M., Bengtsson, E., Nilsson, J., and Jovinge, S. (2004) Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 24, 2137-2142
43. Yoshida, L. S., and Tsunawaki, S. (2008) Expression of NADPH oxidases and enhanced H2O2-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-α. Int. Immunopharmacol. 8, 1377-1385
44. Moe, K. T., Yin, N. O., Naylynn, T. M., Khairunnisa, K., Wutyi, M. A., Gu, Y., Atan, M. S., Wong, M. C., Koh, T. H., and Wong, P. (2011) Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice. J. Cell. Mol. Med. 15, 2601-2613
45. Goodson, N., Marks, J., Lunt, M., and Symmons, D. (2005) Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann. Rheum. Dis. 64, 1595-1601
46. Lee, H. H., Yang, S. S., Vo, M. T., Cho, W. J., Lee, B. J., Leem, S. H., Lee, S. H., Cha, H. J., and Park, J. W. (2013) Tristetraprolin down-regulates IL-23 expression in colon cancer cells. Mol. Cells 36, 571-576
47. Gonzalez-Gay, M. A., Gonzalez-Juanatey, C., Lopez-Diaz, M. J., Piñeiro, A., Garcia-Porrua, C., Miranda-Filloy, J. A., Ollier, W. E., Martin, J., and Llorca, J. (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 57, 125-132
48. Patino, W. D., Kang, J. G., Matoba, S., Mian, O. Y., Gochuico, B. R., and Hwang, P. M. (2006) Atherosclerotic plaque macrophage transcriptional regulators are expressed in blood and modulated by tristetraprolin. Circ. Res. 98, 1282-1289
49. Zhang, H., Taylor, W. R., Joseph, G., Caracciolo, V., Gonzales, D. M., Sidell, N., Seli, E., Blackshear, P. J., and Kallen, C. B. (2013) mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. 33, 1212-1220
50. Kerekes, G., Szekanecz, Z., Dér, H., Sándor, Z., Lakos, G., Muszbek, L., Csipö, I., Sipka, S., Seres, I., Paragh, G., Kappelmayer, J., Szomják, E., Veres, K., Szegedi, G., Shoenfeld, Y., and Soltész, P. (2008) Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: A multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J. Rheumatol. 35, 398-406
51. Dharmashankar, K., and Widlansky, M. E. (2010) Vascular endothelial function and hypertension: Insights and directions. Curr. Hypertens. Rep. 12, 448-455
52. Lai, W. S., Parker, J. S., Grissom, S. F., Stumpo, D. J., and Blackshear, P. J. (2006) Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol. Cell. Biol. 26, 9196-9208
53. Sommer, S. L., Berndt, T. J., Frank, E., Patel, J. B., Redfield, M. M., Dong, X., Griffin, M. D., Grande, J. P., van Deursen, J. M., Sieck, G. C., Romero, J. C., and Kumar, R. (2006) Elevated blood pressure and cardiac hypertrophy after ablation of the gly96/IEX-1 gene. J. Appl. Physiol. 100, 707-716
54. Mangan, S. H., Van Campenhout, A., Rush, C., and Golledge, J. (2007) Osteoprotegerin up-regulates endothelial cell adhesion molecule response to tumor necrosis factor-α associated with induction of angiopoietin- 2. Cardiovasc. Res. 76, 494-505
55. Zhang, J., Guo, H., Mi, Z., Gao, C., Bhattacharya, S., Li, J., and Kuo, P. C. (2009) EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells. Exp. Cell Res. 315, 304-312
56. Ishmael, F. T., Fang, X., Galdiero, M. R., Atasoy, U., Rigby, W. F., Gorospe, M., Cheadle, C., and Stellato, C. (2008) Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation. J. Immunol. 180, 8342-8353
57. McMurray, R. W. (1996) Adhesion molecules in autoimmune disease. Semin. Arthritis Rheum. 25, 215-233
58. Crook, M. F., Southgate, K. M., and Newby, A. C. (2002) Both ICAM-1- and VCAM-1-integrin interactions are important in mediating monocyte adhesion to human saphenous vein. J. Vasc. Res. 39, 221-229
59. Carballo, E., and Blackshear, P. J. (2001) Roles of tumor necrosis factor-α receptor subtypes in the pathogenesis of the tristetraprolin- deficiency syndrome. Blood 98, 2389-2395
60. Greenberg, J. D., Kremer, J. M., Curtis, J. R., Hochberg, M. C., Reed, G., Tsao, P., Farkouh, M. E., Nasir, A., Setoguchi, S., Solomon, D. H., and CORRONA Investigators (2011) Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann. Rheum. Dis. 70, 576-582
61. Al-Aly, Z., Pan, H., Zeringue, A., Xian, H., McDonald, J. R., El-Achkar, T. M., and Eisen, S. (2011) Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis. Transl. Res. 157, 10-18
62. Kundu, S., Ghosh, P., Datta, S., Ghosh, A., Chattopadhyay, S., and Chatterjee, M. (2012) Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis. Free Radic. Res. 46, 1482-1489
63. Ikonomidis, I., Lekakis, J. P., Nikolaou, M., Paraskevaidis, I., Andreadou, I., Kaplanoglou, T., Katsimbri, P., Skarantavos, G., Soucacos, P. N., and Kremastinos, D. T. (2008) Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 117, 2662-2669
64. Carrick, D. M., Lai, W. S., and Blackshear, P. J. (2004) The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis. Arthritis Res. Ther. 6, 248-264
65. Huo, Y., Rangarajan, P., Ling, E. A., and Dheen, S. T. (2011) Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC Neurosci. 12, 49
66. Lim, H., Kim, D., and Lee, S. J. (2013) Toll-like receptor 2 mediates peripheral nerve injury-induced NADPH oxidase 2 expression in spinal cord microglia. J. Biol. Chem. 288, 7572-7579
67. Sandler, H., and Stoecklin, G. (2008) Control ofmRNAdecay by phosphorylation of tristetraprolin. Biochem. Soc. Trans. 36, 491-496
68. Lambeth, J. D., Kawahara, T., and Diebold, B. (2007) Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 43, 319-331
69. Badimon, L., Vilahur, G., and Padro, T. (2010) Nutraceuticals and atherosclerosis: human trials. Cardiovasc. Therap. 28, 202-215
70. Schramm, A., Matusik, P., Osmenda, G., and Guzik, T. J. (2012) Targeting NADPH oxidases in vascular pharmacology. Vascul. Pharmacol. 56, 216-231